Navigation Links
Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery

ration of action, and accumulates over time in the body, it is rarely used to control BP during surgery, and is only used occasionally after surgery.

About Cleviprex

Cleviprex is a novel, investigational drug rationally designed to meet the needs of the acute care practitioner for an intravenous hypertensive agent. It is the first third-generation dihydropyridine calcium channel blocker that acts rapidly and reliably, is vascular- and arterial- selective, and has an ultrashort half-life. Cleviprex recently completed Phase III clinical trials.

MDCO-G

About The Medicines Company

The Medicines Company is committed to delivering innovative, cost- effective acute care products in the worldwide hospital marketplace. The Company markets Angiomax(R) (bivalirudin) in the U.S. and other countries for use in patients undergoing coronary angioplasty, a procedure to clear restricted blood flow in arteries around the heart. The Company also has two products in late-stage development, Cleviprex(TM) (clevidipine) and cangrelor. The Company's website is http://www.themedicinescompany.com.

Statements contained in this press release about The Medicines Company and Cleviprex that are not purely historical, and all other statements that are not purely historical, may be deemed to be forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Without limiting the foregoing, the words "believes," "anticipates" and "expects" and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties that may cause the Company's actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Important factors that may cause or contribute
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
2. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
3. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
4. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
5. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
6. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
10. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
11. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study

Post Your Comments:
(Date:11/6/2009)...irstCall/ -- Roper Industries, Inc. (NYSE: ROP) ...agreement to acquire Verathon, Inc., a leading pro...n Board of Directors has approved the transaction ... approvals and closing conditions, including share...o be completed in early December. ,, Headquart...
(Date:11/6/2009)...FirstCall/ -- Derma Sciences, Inc. (OTC Bullet... products, announced plans to release its third qu...er 16, 2009. The Company will hold a conference ca...m EST. Interested parties should call (866) 788-05...ith passcode 81416481 to access the call. You may ...
(Date:11/6/2009)...irstCall/ -- Virtual Health Technologies, Inc. (OT...reviously confirmed Letter of Intent to sell all h...nologies, Inc (WNDM) is subject to final approval ...I. ,, Shareholder Assurances ,, "We beli...eam and cash realized from the transaction would b...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Cost Conscious Texans Find Relief with Direct Access Lab Testing 52629 1Cost Conscious Texans Find Relief with Direct Access Lab Testing 52629 2Genomma Lab International Announces Second Quarter 2009 Results 52626 1Genomma Lab International Announces Second Quarter 2009 Results 52626 2Genomma Lab International Announces Second Quarter 2009 Results 52626 3Genomma Lab International Announces Second Quarter 2009 Results 52626 4Genetically engineered bacteria compute the route 13179 1Genetically engineered bacteria compute the route 13179 2
...a Suggest Majority of Pompe Patients May Be Amenab...rapy, CRANBURY, N.J., March 13 Amicus Therapeuti...olecule, orally administered,pharmacological chape...announced today that the Company will present posi...ree Phase 1 studies of AT2220 (1-deoxynojirimycin,...
...TH SAN FRANCISCO, Calif., March 13 Raven,biotechn... the discovery,and development of monoclonal antib... that it has initiated a Phase 2 study of RAV12, i...itabine in the treatment of,patients with metastat...cer Study will be conducted at approximately,20 in...
Other Medicine Technology:Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 2Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 3Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 4Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer 2Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer 3
(Date:11/8/2009)... HOLLYWOOD, Calif., Nov. 8 /PRNewswire-USNewswire/...ation of Babies luncheon to recognize prominent in...hildren and who are role models for March of Dimes...art of the March of Dimes November Prematurity Awa...sts were urged to join the fight for preemies! ,...
(Date:11/7/2009)... WASHINGTON , Nov. 7 ...ay in support of H.R. 3962, the Affordable Health ...legislation later tonight. Below are the Speaker,... know, is an historic moment for our nation and fo...s of every party and political philosophy -- as fa...
(Date:11/7/2009)... HOUSTON, Nov. 7 The Am... Lisa James, Director of Health at the Family Viol...guished Service today at its semi-annual policy-ma...ice is the highest honor the AMA House of Delegate...tp://www.newscom.com/cgi-bin/prnh/20081209/AMALOGO...
(Date:11/7/2009)... HOUSTON, Nov. 7 Calling this a "d...on (AMA), the AMA President J. James Rohack, M.D.,...cians from all state and medical specialty societi...making meeting, where health system reform will to...m/cgi-bin/prnh/20081209/AMALOGO ) ,, "Over th...
(Date:11/7/2009)... WASHINGTON, Nov. 7 Wit...g, antichoice extremists are holding the entire bi...hey are demanding that the bill go far beyond the ...incorporated into the original bill. In an outrag...arly Saturday afternoon, antichoice Democrats are ...
Breaking Medicine News(10 mins):Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA Honors Family Violence Prevention Expert 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2
...y suggests that the belief of being watched makes ...not real//. A Newcastle University team moni...sty box" while they bought a drink. They obs... The poster might have generated a feeling ...
...rt by the Comptroller and Auditor General criticiz...aid that it is ill-equipped to carry out medical r...ccident. The report was complied after audit...he report said that most railways hospitals were i...
...es is on the rise in New Zealand. Hence Pharmac de...hose who have serious fluctuations in blood sugar ...ine or Lantus at a subsidized rate from July 1. ... He also said that the insulin would not be pr...
...gunya, a relatively rare form of mosquito-transmit... Pradesh and hundreds are suffering from the disea... has been reported in Madhya Pradesh for the first...ture to the victim as a result of the arthritic sy...
... born to young mothers are more likely to live lon...versity of Chicago's Center on Aging// told at the...ge at which a mother gives birth has a major impac...100 and above is double for a child born to a woma...
...ing to the recent tests conducted by the Analytica... found to be potable//. Tasmanian Greens condu...e Upper Grassy Dam waters. This was followed b... testing. It was found that the water had metal co...
Other Medicine News:
...c Instruments incorporate a layered design unique ...monitored to prevent stray electrosurgical burns a...ion failure or capacitive coupling; a well-documen...lt into all AEM Instruments provides a neutral ret...
...Laparofan™ single-use laparoscopic fan retra.... It is indicated for endoscopic surgery and may b...aparofan™ single-use J-shaped laparoscopic f... with the Auto Suture™ Laparolift™ arm...
Micro-dissecting Forceps
10mm Anvil Grasper
Medicine Products: